ReviewFrontiers in immunology2026

Efgartigimod for Guillain-Barré syndrome: rationale, clinical evidence, and future perspectives.

Xinyu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.